Hologic Inc stock hits 52-week high at $76.01 By Investing.com

Hologic Inc. stock reached a new 52-week high of $76.01, demonstrating strong investor confidence in the medical technology company with a 24.3% return over the past year. This comes despite recent Q1 earnings missing analyst expectations, while the company also prepares for a CEO transition and celebrates FDA approval for its Aptima HPV Assay. InvestingPro analysis indicates the stock is fairly valued and has a “GREAT” financial health rating.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin